Warning: Invalid argument supplied for foreach() in
/home/r3716923/public_html/kringle-pharma.com/wp-content/themes/kringle_pharma/view/single/default.php on line
21
2009.01.28
ChronSeal Phase I/II started in Sweden PDF
Kringle Pharma Commences a Phase I/II Clinical Trial in Sweden on ChronSeal®, a Recombinant Human HGF-Based Therapy for the Treatment of Skin Ulcers.